Prospective, randomized study comparing highly purified urinary follicle-stimulating hormone (FSH) and recombinant FSH for in vitro fertilization/intracytoplasmic sperm injection in patients with polycystic ovary syndrome

被引：9
|
作者：
Aboulghar, Mohamed [1 ,2 ]
Saber, Waleed [1 ,2 ]
Amin, Yahia [1 ]
Aboulghar, Mona [1 ,2 ]
Mansour, Ragaa [1 ]
Serour, Gamal [1 ]
机构：
[1] Egyptian IVF Ctr, Cairo 11431, Egypt
[2] Cairo Univ, Dept Obstet & Gynecol, Fac Med, Cairo, Egypt
来源：
FERTILITY AND STERILITY | 2010年 / 94卷 / 06期
关键词：
CONSENSUS; CRITERIA;
D O I：
10.1016/j.fertnstert.2010.01.051
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
In a randomized study comparing purified urinary FSH with recombinant FSH for IVF/ intracytoplasmic sperm injection in patients with polycystic ovary syndrome, there was no significant difference between the mean total dose of FSH used, duration of stimulation, number of retrieved oocytes, number of mature oocytes, number of embryos transferred, or the ongoing pregnancy rate between the two groups. However, there were significantly more fertilized oocytes, a higher fertilization rate, more top-quality embryos, and more cryopreserved embryos in the urinary FSH group. (Fertil Steril (R) 2010;94:2332-4. (C) 2010 by American Society for Reproductive Medicine.)
引用
收藏
页码：2332 / 2334
页数：3
相关论文
共 50 条
  • [31] A prospective, randomized controlled trial comparing the efficacy of recombinant follicle-stimulating hormone in three different in vitro fertilization protocols
    Ravhon, A
    Lawrie, H
    Ellenbogen, A
    Lavery, S
    Trew, G
    Winston, R
    FERTILITY AND STERILITY, 2000, 73 (05) : 908 - 912
  • [32] Recombinant human follicle-stimulating hormone as a pretreatment for idiopathic oligoasthenoteratozoospermic patients undergoing intracytoplasmic sperm injection
    Caroppo, E
    Niederberger, C
    Vizziello, GM
    D'Amato, G
    FERTILITY AND STERILITY, 2003, 80 (06) : 1398 - 1403
  • [33] Ovulation induction with urinary FSH or recombinant FSH in polycystic ovary syndrome patients undergoing to IVF: A prospective randomized analysis of results and cost-effectiveness
    Carone, D.
    Chiappetta, R.
    PROCEEDINGS OF THE 14TH WORLD CONGRESS ON IN VITRO FERTILIZATION & 3RD WORLD CONGRESS ON IN VITRO MATURATION, 2007, : 13 - 13
  • [34] Characteristics of consecutive in vitro fertilization cycles among patients treated with follicle-stimulating hormone (FSH) and human menopausal gonadotropin versus FSH alone
    Sills, ES
    Schattman, GL
    Veeck, LL
    Liu, HC
    Prasad, M
    Rosenwaks, Z
    FERTILITY AND STERILITY, 1998, 69 (05) : 831 - 835
  • [35] Human Menopausal Gonadotropin versus Recombinant FSH in Polycystic Ovary Syndrome Patients Undergoing In Vitro Fertilization
    Turkcapar, Ayse Figen
    Seckin, Berna
    Onalan, Gogsen
    Ozdener, Tulin
    Batioglu, Sertac
    INTERNATIONAL JOURNAL OF FERTILITY & STERILITY, 2013, 6 (04) : 238 - 243
  • [36] Comparing Corifollitropin Alfa to Recombinant Follicle-STIMULATING Hormone in Poor Responder Patients Undergoing Intracytoplasmic Injection: A Randomized Clinical Trial
    Saharkhiz, Nasrin
    Salehpour, Saghar
    Hosseini, Sedigheh
    Hajizadeh, Nazanin
    CRESCENT JOURNAL OF MEDICAL AND BIOLOGICAL SCIENCES, 2024, 11 (04): : 176 - 182
  • [37] Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis
    Alberto Revelli
    Francesca Poso
    Gianluca Gennarelli
    Federica Moffa
    Giuseppina Grassi
    Marco Massobrio
    Reproductive Biology and Endocrinology, 4
  • [38] Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis
    Revelli, Alberto
    Poso, Francesca
    Gennarelli, Gianluca
    Moffa, Federica
    Grassi, Giuseppina
    Massobrio, Marco
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2006, 4 (1)
  • [39] Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimullerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection
    Arce, Joan-Carles
    Andersen, Anders Nyboe
    Fernandez-Sanchez, Manuel
    Visnova, Hana
    Bosch, Ernesto
    Garcia-Velasco, Juan Antonio
    Barri, Pedro
    de Sutter, Petra
    Klein, Bjarke M.
    Fauser, Bart C. J. M.
    FERTILITY AND STERILITY, 2014, 102 (06) : 1633 - U456
  • [40] Elevated efficacy of highly purified human menopausal gonadotropin (HP hMG) for intracytoplasmic sperm injection (ICSI): Results of a prospective, randomized, controlled trial comparing HP hMG to recombinant Follicle-Stimulating hormone (r-hFSH).
    Kilani, Z
    Dakkak, A
    Ghunaim, S
    Cognigni, GE
    Melappioni, S
    Filicori, M
    FERTILITY AND STERILITY, 2002, 78 (03) : S53 - S53
12345